🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the effect of GS-6615 in adults with chronic stabl...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-05
Trial ID
NCT02377336
The primary objective of this study is to evaluate the pharmacokinetic (PK)...
Status
Completed
Location
Multiple Locations
Start Date
2015-03-19
Trial ID
NCT02412098
Treatments Being Tested
The primary objective of the study is to evaluate the effect of oral elecla...
Status
Completed
Location
University of Rochester Medical Center/Strong Memorial Hospital
Start Date
2015-07-20
Trial ID
NCT02365506
Treatments Being Tested
The primary objective of this study was to evaluate the effect of eleclazin...
Status
Terminated
Location
Cedars-Sinai Heart Institute
Start Date
2015-02-05
Trial ID
NCT02291237
Treatments Being Tested
This is a phase 1, single-blind, randomized, placebo-controlled, multiple a...
Status
Completed
Location
Investigational Site
Start Date
2013-05
Trial ID
NCT01847391
The primary objective of this study is to evaluate the effect of oral elecl...
Status
Terminated
Location
Mayo Clinic Rochester
Start Date
2014-12-17
Trial ID
NCT02300558
Treatments Being Tested
The primary objective of this study is to evaluate the effect of eleclazine...
Status
Completed
Location
Cardiovascular Associates of Mesa
Start Date
2014-09
Trial ID
NCT02104583
Treatments Being Tested
This mechanism of action study is to evaluate the effect of oral GS-6615 on...
Status
Completed
Location
University of Rochester Medical Center/Strong Memorial Hospital
Start Date
2013-05
Trial ID
NCT01849003
Treatments Being Tested
This study will evaluate the effect of oral GS-6615 on QTc interval in heal...
Status
Completed
Location
Spaulding Clinical Research, LLC
Start Date
2015-02
Trial ID
NCT02365532
Treatments Being Tested
This study will evaluate the pharmacokinetics (PK), safety, and tolerabilit...
Status
Completed
Location
Multiple Locations
Start Date
2015-05
Trial ID
NCT02441829
Treatments Being Tested